成人免费xx,国产又黄又湿又刺激不卡网站,成人性视频app菠萝网站,色天天天天

ChemicalBook--->CAS DataBase List--->1152425-66-5

1152425-66-5

1152425-66-5 Structure

1152425-66-5 Structure
IdentificationBack Directory
[Name]

Luseogliflozin (hydrate)
[CAS]

1152425-66-5
[Synonyms]

TS 071 hydrate
Luseogliflozin (hydrate)
(2S,3R,4R,5S,6R)-2-[5-[(4-ethoxyphenyl)methyl]-2-methoxy-4-methylphenyl]-6-(hydroxymethyl)thiane-3,4,5-triol:hydrate
[Molecular Formula]

C23H32O7S
[MDL Number]

MFCD34574461
[MOL File]

1152425-66-5.mol
[Molecular Weight]

452.56
Hazard InformationBack Directory
[Description]

Luseogliflozin hydrate, which is an SGLT2 inhibitor approved in Japan in March 2014 for the treatment of type 2 diabetes, was discovered by Taisho Pharmaceutical and jointly developed and marketed with Novartis as Lusefi®. Luseogliflozin selectively binds and inhibits human SGLT2 with a Ki of 1.10 nM and IC50 value of 2.26 nM.
[Synthesis]

The most likely synthetic route capable of producing luseogliflozin on process scale has been reported by Taisho. Commercially available 4-methoxy- 2-methyl-benzoic acid (160) was brominated in the presence of a catalytic amount of iron powder, generating a 1:1 mixture of 3- and 5-bromo derivatives which were separable by recrystallization from methanol to provide the desired regioisomer 161 in 34% yield. Next, benzoic acid 161 was treated with oxalyl chloride to give the corresponding acyl chloride 162, which underwent a Friedel¨C Crafts reaction with ethoxybenzene (163) to afford 164 in 82% yield for the two step sequence. The dibenzylic ketone 164 was reduced using triethylsilane and boron trifluoride to give aglycon 165 in 99% yield. The Grignard reagent prepared from bromide 165 was then alkylated with thiolactone 166 (prepared from 5- thio-D-glucose penta-O-acetate (169) as illustrated in Scheme 27) to give rise to hemithioacetal 167 in 75% yield. This compound underwent stereoselective reduction to provide thioglycoside 168 in 77% yield. Hydrogenation of 168 resulted in global debenzylation to provide the desired product luseogliflozin (XIX) in 81% yield.
The preparation of key thiolactone 166 started from 5-thio-Dglucose penta-O-acetate (169) ; 169 could be prepared by eight steps from commercially available Dglucurono- 3,6-lactone. The anomeric acetyl group of 169 was selectively removed by hydrazine and acetic acid at room temperature giving compound 170 in 70% yield. Subsequently, the anomeric hydroxyl group of 170 was protected with tetrahydropyran. Then, all acetyl groups of 171 were removed by Zempl¨|n deacetylation, and the resulting hydroxyl groups of 172 were further protected by benzyl groups using benzylbromide with sodium hydride to generate 173. The tetrahydropyranyl group of 173 was removed using pyridinium p-toluenesulfonate (PPTS), followed by DMSO oxidation to provide 166 in 82% yield, by way of 174.

Synthesis_1152425-66-5

1152425-66-5 suppliers list
Company Name: Lynnchem  
Tel: 86-(0)29-85992781 17792393971
Website: http://www.lynnchem.com/
Company Name: Novachemistry  
Tel: 44-20819178-90 02081917890
Website: https://www.novachemistry.com/
Company Name: Suzhou Haiben Pharmaceutical Co., Ltd  
Tel: 14760821013 13564957716
Website:
Company Name: TargetMol Chemicals Inc.  
Tel: 15002134094
Website: https://www.targetmol.cn/
Tags:1152425-66-5 Related Product Information